These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12556647)

  • 41. Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
    Puttnam R; Davis BR; Pressel SL; Whelton PK; Cushman WC; Louis GT; Margolis KL; Oparil S; Williamson J; Ghosh A; Einhorn PT; Barzilay JI;
    JAMA Intern Med; 2017 Jan; 177(1):67-76. PubMed ID: 27893045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.
    Reisin E; Graves JW; Yamal JM; Barzilay JI; Pressel SL; Einhorn PT; Dart RA; Retta TM; Saklayen MG; Davis BR;
    J Hypertens; 2014 Jul; 32(7):1503-13; discussion 1513. PubMed ID: 24842697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial.
    Mukhtar O; Cheriyan J; Cockcroft JR; Collier D; Coulson JM; Dasgupta I; Faconti L; Glover M; Heagerty AM; Khong TK; Lip GYH; Mander AP; Marchong MN; Martin U; McDonnell BJ; McEniery CM; Padmanabhan S; Saxena M; Sever PJ; Shiel JI; Wych J; Chowienczyk PJ; Wilkinson IB
    Am Heart J; 2018 Oct; 204():102-108. PubMed ID: 30092411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
    Wright JT; Probstfield JL; Cushman WC; Pressel SL; Cutler JA; Davis BR; Einhorn PT; Rahman M; Whelton PK; Ford CE; Haywood LJ; Margolis KL; Oparil S; Black HR; Alderman MH;
    Arch Intern Med; 2009 May; 169(9):832-42. PubMed ID: 19433694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Davis BR; Kostis JB; Simpson LM; Black HR; Cushman WC; Einhorn PT; Farber MA; Ford CE; Levy D; Massie BM; Nawaz S;
    Circulation; 2008 Nov; 118(22):2259-67. PubMed ID: 19001024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemia.
    Geraci TS; Geraci SA
    J Cardiovasc Nurs; 2003; 18(5):389-95. PubMed ID: 14680343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
    Düsing R
    MMW Fortschr Med; 2003; 145 Suppl 1():6. PubMed ID: 12958795
    [No Abstract]   [Full Text] [Related]  

  • 49. Hats off to an old blood pressure drug. For treating high blood pressure, an old--and inexpensive--medication is a great place to start or a good one to add.
    Harv Heart Lett; 2003 Mar; 13(7):1-2. PubMed ID: 12654580
    [No Abstract]   [Full Text] [Related]  

  • 50. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
    Wepner U
    MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
    [No Abstract]   [Full Text] [Related]  

  • 51. ALLHAT. Is it all hat?
    Glancy DL
    J La State Med Soc; 2003; 155(2):68-70. PubMed ID: 12778985
    [No Abstract]   [Full Text] [Related]  

  • 52. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
    Yamal JM; Oparil S; Davis BR; Alderman MH; Calhoun DA; Cushman WC; Fendley HF; Franklin SS; Habib GB; Pressel SL; Probstfield JL; Sastrasinh S;
    J Am Soc Hypertens; 2014 Nov; 8(11):808-19. PubMed ID: 25455006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.
    Haywood LJ; Davis BR; Piller LB; Simpson LM; Ghosh A; Einhorn PT; Ford CE; Probstfield JL; Soliman EZ; Wright JT;
    J Natl Med Assoc; 2018 Aug; 110(4):343-351. PubMed ID: 30126559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
    Proschan M; Ford CE; Cutler JA; Graumlich JF; Pavlik V; Cushman WC; Davis BR; Alderman MH; Gordon D; Furberg CD; Franklin SS; Blumenthal SS; Castaldo RS; Preston RA;
    Stat Med; 2013 Feb; 32(5):884-97. PubMed ID: 22961832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strengthening diuretics' role in hypertension.
    Manag Care; 2010 Sep; 19(9):46. PubMed ID: 20931893
    [No Abstract]   [Full Text] [Related]  

  • 56. ALLHAT and beyond.
    Alderman MH
    Am J Hypertens; 2003 Jun; 16(6):512-4. PubMed ID: 12799104
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
    Juraschek SP; Simpson LM; Davis BR; Beach JL; Ishak A; Mukamal KJ
    Hypertension; 2019 Oct; 74(4):1033-1040. PubMed ID: 31476905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
    Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A family physician questions the conclusions from ALLHAT.
    Standridge JB
    Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical study of the month. Which initial antihypertensive? Results from the ALLHAT trial].
    Scheen AJ; Krzesinski JM
    Rev Med Liege; 2003 Jan; 58(1):47-52. PubMed ID: 12647599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.